Literature DB >> 27932127

Recurrent Hepatocellular Carcinoma After Liver Transplantation: Analysis of Risk Factors.

E Perea Del Pozo1, C Bernal Bellido2, M Sendín Matín2, C Cepeda Franco2, J M Álamo Martínez2, G Suarez Artacho2, L M Marín Gómez2, J Padillo Ruiz2, M Á Gomez Bravo2.   

Abstract

BACKGROUND: Survival after orthotopic liver transplantation (LT) for hepatocellular carcinoma (HCC) is influenced by tumor recurrence. This study examines the survival of patients who underwent LT for HCC and developed recurrence of tumor after transplantation.
METHODS: A retrospective analysis was performed of the 200 patients who underwent LT secondary to HCC from 1990 to 2014. We excluded 19 patients from the study owing to early postoperative deaths in the 1st month. We divided our sample into 2 groups according to the presence of recurrence. We performed a univariate analysis to identify variables that are significantly associated with the risk of recurrence. Afterward we use multivariate analysis regression analysis to find independent significance.
RESULTS: Univariate analysis shows significant relationship between high Edmondson-Steiner grades (G3-G4) and the development of tumor recurrence. Tumor size, vascular invasion, and capsular invasion were found to be independent risk factors of tumor recurrence in the multivariate analysis.
CONCLUSIONS: Tumor recurrence defines survival of patients who underwent LT for HCC. In this study we discuss which histologic factor are associated with higher risk of tumor recurrence, and therefore a negative the impact on patient's survival. Copyright Â
© 2016 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2016        PMID: 27932127     DOI: 10.1016/j.transproceed.2016.09.020

Source DB:  PubMed          Journal:  Transplant Proc        ISSN: 0041-1345            Impact factor:   1.066


  6 in total

Review 1.  Hepatocellular carcinoma: when is liver transplantation oncologically futile?

Authors:  André Viveiros; Heinz Zoller; Armin Finkenstedt
Journal:  Transl Gastroenterol Hepatol       Date:  2017-07-24

Review 2.  Using a weaning immunosuppression protocol in liver transplantation recipients with hepatocellular carcinoma: a compromise between the risk of recurrence and the risk of rejection?

Authors:  Roberta Angelico; Alessandro Parente; Tommaso Maria Manzia
Journal:  Transl Gastroenterol Hepatol       Date:  2017-09-21

3.  Recurrence of Hepatocellular Carcinoma After Liver Transplantation is Associated with Episodes of Acute Rejections.

Authors:  Safak Gül-Klein; Anika Kästner; Philipp Konstantin Haber; Felix Krenzien; Simon Wabitsch; Alexander Krannich; Andreas Andreou; Dennis Eurich; Frank Tacke; David Horst; Johann Pratschke; Moritz Schmelzle
Journal:  J Hepatocell Carcinoma       Date:  2021-03-18

Review 4.  Immune Checkpoint Inhibitors as Therapy to Down-Stage Hepatocellular Carcinoma Prior to Liver Transplantation.

Authors:  Nitin N Katariya; Blanca C Lizaola-Mayo; David M Chascsa; Emmanouil Giorgakis; Bashar A Aqel; Adyr A Moss; Pedro Luiz Serrano Uson Junior; Mitesh J Borad; Amit K Mathur
Journal:  Cancers (Basel)       Date:  2022-04-19       Impact factor: 6.575

5.  Survival outcomes of liver transplantation for hepatocellular carcinoma in patients with normal, high and very high preoperative alpha-fetoprotein levels.

Authors:  Wong Hoi She; Albert Chi Yan Chan; Tan To Cheung; Chung Mau Lo; Kenneth Siu Ho Chok
Journal:  World J Hepatol       Date:  2018-02-27

6.  Risk Factors for Hepatocellular Carcinoma Recurrence and Survival after Liver Transplantation in Patients with HCV-Related Cirrhosis.

Authors:  Raphael Iglesias de Oliveira Vidal; Edison Iglesias de Oliveira Vidal; Basilio de Bragança Pereira; Cachimo Combo Assane; Alexandre Ribeiro; Emilia Matos do Nascimento; Fernando Gomes Romeiro; Joaquim Ribeiro Filho
Journal:  Biomed Res Int       Date:  2020-10-17       Impact factor: 3.411

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.